Home/Filings/4/0001831283-23-000018
4//SEC Filing

Larson Yi 4

Accession 0001831283-23-000018

CIK 0001831283other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:12 PM ET

Size

5.5 KB

Accession

0001831283-23-000018

Insider Transaction Report

Form 4
Period: 2023-01-20
Larson Yi
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-20+464,099464,099 total
    Exercise: $2.66Exp: 2033-01-20Ordinary Shares (464,099 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the option will vest and become exercisable on January 20, 2024; the remainder shall vest and become exercisable in 36 equal monthly installments such that the option shall be fully vested on January 20, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Issuer

LianBio

CIK 0001831283

Entity typeother

Related Parties

1
  • filerCIK 0001785987

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:12 PM ET
Size
5.5 KB